“…For example, α/β-peptides which are faithful α-helix mimics have been developed as inhibitors of protein-protein interactions or as receptor ligands with improved pharmacological properties, increased resistance to proteolytic degradation and in some cases prolonged duration of action in vivo (Boersma et al, 2011;Checco et al, 2015;Cheloha, Maeda, Dean, Gardella, & Gellman, 2014;Horne et al, 2009;Johnson et al, 2014;Johnson & Gellman, 2013;Kritzer, Hodsdon, & Schepartz, 2005;Kritzer, Stephens, Guarracino, Reznik, & Schepartz, 2005;Lee et al, 2009;Liu, Cheloha, Watanabe, Gardella, & Gellman, 2018;Liu et al, 2019;Michel, Harker, Tirado-Rives, Jorgensen, & Schepartz, 2009). Furthermore, the ability to link sequence and folding within nonbiological synthetic foldamers can be exploited to create architectures reaching the size and complexity of small proteins (tertiary and quaternary structures) (Horne & Grossmann, 2020;Pappas et al, 2020) or molecular strands that display molecular recognition properties and functions beyond those found in nature (Ferrand & Huc, 2018;Gan et al, 2017).…”